Delhi High Court's division bench reserves verdict on Novo Nordisk's appeal against order allowing Dr Reddy's and Sun Pharma to export generic semaglutide. Decision will impact India's growing diabetes drug market.
Hero MotoCorp patents the design of its upcoming Vida VXZ electric motorcycle, co-developed with Zero Motorcycles. The streetfighter-style bike features unique styling and advanced components, hinting at a launch later this year or in 2027.
India has multiple legal tools under its Patents Act to address public health concerns while complying with international agreements. This analysis explores how the country can prevent patent abuse.
Shaadi.com founder Anupam Mittal criticizes Google, Apple, Amazon, Meta, and Microsoft for allowing digital free-riders to exploit brand trust after a major Bombay High Court victory.
A Tesla patent highlighting four Indian-origin engineers unexpectedly triggered a heated political debate about H-1B visas and immigrant contributions to American innovation.
Eros International Media Ltd files a ₹84 crore IP suit in Bombay High Court, alleging Tere Ishk Mein was illegally promoted as a spiritual sequel to its 2013 hit film Raanjhanaa.
Chinese AR glasses maker Xreal files lawsuit against competitor Viture in Texas federal court, alleging patent infringement on key technologies ahead of Apple's expected market entry.
Hachette Book Group and Cengage Group ask a California federal court to intervene in a class action against Google over alleged misuse of copyrighted material to train AI systems.
Indian pharma companies face margin pressure from Revlimid patent expiry and US competition, but strong domestic sales and core business momentum may cushion the blow in Q3 FY26.
Oscar-winning actor Matthew McConaughey has registered his voice and image with US patent authorities to prevent unauthorized AI use. His legal team explains this proactive move aims to protect his identity and capture value from new technology.
Patent laws designed for slower eras now hinder progress as AI accelerates discovery. Historical examples show how extended monopolies block innovation.
Delhi High Court overturns injunction, allowing Zydus Lifesciences to manufacture and sell biosimilar of Nivolumab, making cancer treatment 70% cheaper in India.
Indo German Carbons Limited ramps up brand protection with new packaging and legal action following repeated trademark infringement. Learn how the company is safeguarding its market reputation.
Indo German Carbons Limited intensifies its fight against trademark infringement with new legal and technological safeguards to protect its brand identity and market share. Learn about their proactive strategy.
Delhi High Court permits Zydus Lifesciences to sell its biosimilar of cancer drug Nivolumab until patent expiry in May 2026. Court mandates detailed sales records to protect innovator Squibb's interests. Read more.
Perplexity Patents, an AI-powered tool, helps innovation teams validate ideas and explore patent landscapes using natural language, preventing costly late-stage discoveries. Discover how it streamlines R&D.
Mandya Institute of Medical Sciences announces 6 joint patent applications for AI-driven cancer detection tech, marking a major step in establishing a Medical AI & Robotics hub in Karnataka. Discover the breakthrough.
A Gurugram commercial court has issued an interim injunction against BIG Red Education for unauthorized use of the 'HARVARD' trademark in its programs and websites, citing potential reputational harm.
Natco Pharma files suit in Delhi High Court seeking revocation of Novo Nordisk's patent on diabetes drug semaglutide. Court issues notice, hearing set for Feb 5. Indian pharma race for generic Ozempic heats up.
SIB SHInE at KGMU, with IIT-Kanpur, patents a wearable sensor for early breast abnormality detection. A breakthrough in med-tech innovation. Read about the collaborative triumph.
Delhi High Court has issued a landmark order to block websites illegally streaming Warner Bros content like 'Friends' and 'Stranger Things'. Read the full details of this major anti-piracy move.
Panjab University's Design Innovation Centre receives an Indian patent for its 'Grass Printer' robot. This autonomous machine can cut grass at varying heights to print messages, symbols, and intricate designs on large lawns, revolutionizing automated land
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
Former Rajasthan agriculture minister Prabhu Lal Saini secures patents for three indigenous date palm varieties, ST-1, ST-2, and ST-3, boosting local cultivation. Discover his 10-year research journey.
Punjab Agricultural University patents a groundbreaking contraceptive bait for rodents, offering a humane and effective solution to protect crops and public health. Learn about this innovative pest control method.
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
A new working paper addresses the critical issue of AI models using journalists' copyrighted work for training without consent or compensation. Explore the search for a balanced solution.
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.